After further breakdown by the tumor grading (Supplementary Figure S1), we found the grade III glioma revealed a survival difference between the high and low CKAP2L expression groups at TCGA and CGGA datasets (p < 0.001 and p = 0.017, respectively). The gene discussed is CKAP2L; the disease is glioma.